Snowball logo
logo
CLDX

Celldex Therapeutics Inc

CLDX NASDAQ
$23.76+$1.18  (5.23%)

Frequently asked questions

What sector does Celldex Therapeutics Inc (CLDX) operate in?

Celldex Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Celldex Therapeutics Inc (CLDX) current stock price?

As of the latest data, Celldex Therapeutics Inc stock price is $23.76, with a previous close of $22.58. Celldex Therapeutics Inc gained $1.18 in the last trading session, representing a 5.23% increase.

What is Celldex Therapeutics Inc (CLDX) current market capitalization?

Celldex Therapeutics Inc market cap is approximately 1.58 billion.

What is Celldex Therapeutics Inc (CLDX) Earnings Per Share (EPS)?

The trailing EPS is -$3.26, and the forward EPS is -$4.42.

What is Celldex Therapeutics Inc (CLDX) EBITDA?

Celldex Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -72.79 million.

Does Celldex Therapeutics Inc (CLDX) pay dividends?

No. Celldex Therapeutics Inc does not pay a dividend.

When is Celldex Therapeutics Inc (CLDX) next earnings report?

Celldex Therapeutics Inc is expected to release its next earnings report on December 31, 2025.

What is Celldex Therapeutics Inc (CLDX) beta (volatility) score?

Celldex Therapeutics Inc has a beta of 1.196, meaning its volatility is roughly in line with the market.